Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

51.21
Delayed Data
As of Jul 31
 +0.47 / +0.93%
Today’s Change
26.02
Today|||52-Week Range
78.72
-1.08%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close50.74
Today’s open50.85
Day’s range49.89 - 52.20
Volume548,850
Average volume (3 months)674,584
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-59.89%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book5.94

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.80+4.88%
THRXTheravance Inc+1.06+7.43%
TTPHTetraphase Pharmaceu...-0.16-0.34%
MNKDMannkind Corp-0.17-3.81%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$1.21
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Executive VP-Research, Operations &
Technology
Neil Gregory Almstead
Corporate headquarters
South Plainfield, New Jersey

Forecasts